Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits

Frontiers in Behavioral Neuroscience

Volumn 8, Issue APR, 2014, Pages

  Pei, Ju Chun ^a   Liu, Chih Min ^b   Lai, Wen Sung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chizophrenia; Cognitive function; GABAergic interneuron; Hippocampus; Transmembrane domain Nrg1 mutant mice; Valproate

Indexed keywords

CALRETININ; DIZOCILPINE; GLUTAMATE DECARBOXYLASE 67; METHAMPHETAMINE; NEU DIFFERENTIATION FACTOR; PARVALBUMIN; PENTETRAZOLE; VALPROIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; EXPERIMENTAL HYPERACTIVITY; FEMALE; GABAERGIC SYSTEM; HAPLOINSUFFICIENCY; HETEROZYGOTE; HIPPOCAMPAL CA1 REGION; HOLE BOARD TEST; HOT PLATE TEST; INTERNEURON; MALE; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OPEN FIELD TEST; PROTEIN DOMAIN; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SEIZURE; SENSORY GATING; SOCIAL RECOGNITION TEST; STARTLE REFLEX; SUCROSE PREFERENCE TEST; TRANSMEMBRANE DOMAIN; YOUNG ADULT;

EID: 84898470506     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00126     Document Type: Article

References (99)

1. Abe, Y., Namba, H., Zheng, Y., and Nawa, H. (2009). In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 161, 95-110. doi: 10.1016/j.neuroscience.2009.03.022
2. Addington, A. M., Gornick, M., Duckworth, J., Sporn, A., Gogtay, N., Bobb, A., et al. (2005). GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol. Psychiatry 10, 581-588. doi: 10.1038/sj.mp.4001599
3. Agim, Z. S., Esendal, M., Briollais, L., Uyan, O., Meschian, M., Martinez, L. A., et al. (2013). Discovery, validation and characterization of Erbb4 and Nrg1 haplo- types using data from three genome-wide association studies of schizophrenia. PLoS ONE 8:e53042. doi: 10.1371/journal.pone.0053042
4. Bao, J., Wolpowitz, D., Role, L. W., and Talmage, D. A. (2003). Back signaling by the Nrg-1 intracellular domain. J. Cell Biol. 161, 1133-1141. doi: 10.1083/jcb.200212085
5. Barros, C. S., Calabrese, B., Chamero, P., Roberts, A. J., Korzus, E., Lloyd, K., et al. (2009). Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 106, 4507-4512. doi: 10.1073/pnas.0900355106
6. Bertram, I., Bernstein, H. G., Lendeckel, U., Bukowska, A., Dobrowolny, H., Keilhoff, G., et al. (2007). Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression. Ann. N.Y. Acad. Sci. 1096, 147-156. doi: 10.1196/annals.1397.080
7. - knock-outs compared with wild-type mice. J. Neurosci. 27, 4519-4529. doi: 10.1523/JNEUR0SCI.4314-06.2007
8. Boucher, A. A., Arnold, J. C., Duffy, L., Schofield, P. R., Micheau, J., and Karl, T. (2007). Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects ofDelta9-tetrahydrocannabinol. Psychopharmacology(Berl.) 192, 325-336. doi: 10.1007/s00213-007-0721-3
9. Brooks, S. P., and Dunnett, S. B. (2009). Tests to assess motor phenotype in mice: a user's guide. Nat. Rev. Neurosci. 10, 519-529. doi:10.1038/nrn2652
10. Cahill, M. E., Jones, K. A., Rafalovich, I., Xie, Z., Barros, C. S., Muller, U., et al. (2012). Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition. Mol. Psychiatry17, 99-107. doi: 10.1038/mp.2011.35
11. Chen, Y., Hancock, M. L., Role, L.W., and Talmage, D. A. (2010). Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development ofcortical neurons. J. Neurosci. 30, 9199-9208. doi: 10.1523/JNEUROSCI.0605-10.2010
12. Chen, Y. C., Chen, Y. W., Hsu, Y. F., Chang, W. T., Hsiao, C. K., Min, M. Y., et al. (2012). Akt1 deficiency modulates reward learning and reward prediction error in mice. Genes Brain Behav. 11, 157-169. doi: 10.1111/j.1601- 183X.2011.00759.x
13. Chen, Y. J., Johnson, M. A., Lieberman, M. D., Goodchild, R. E., Schobel, S., Lewandowski, N., et al. (2008). Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J. Neurosci. 28, 6872-6883. doi: 10.1523/JNEUROSCI.1815- 08.2008
14. Chen, Y. W., Kao, H. Y., Min, M. Y., and Lai, W. S. (2014). A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis. Schizophr. Bull. 40, 388-398. doi: 10.1093/schbul/sbt031.
15. Chen, Y. W., and Lai, W. S. (2011). Behavioral phenotyping of v-akt murine thymoma viral oncogene homolog 1-deficient mice reveals a sex-specific prepulse inhibition deficit in females that can be partially alleviated by glycogen synthase kinase-3 inhibitors but not by antipsychotics. Neuroscience 174, 178-189. doi: 10.1016/j.neuroscience.2010.09.056.
16. Chesworth, R., Downey, L., Logge, W., Killcross, S., and Karl, T. (2012). Cognition in female transmembrane domain neuregulin 1 mutant mice. Behav. Brain Res. 226, 218-223. doi: 10.1016/j.bbr.2011.09.019.
17. Corfas, G., Rosen, K. M., Aratake, H., Krauss, R., and Fischbach, G. D. (1995). Differential expression of ARIA isoforms in the rat brain. Neuron 14, 103-115. doi: 10.1016/0896-6273(95)90244-9.
18. Csoka, A. B., and Szyf, M. (2009). Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med. Hypotheses 73, 770-780. doi: 10.1016/j.mehy.2008.10.039.
19. Deakin, I. H., Law, A. J., Oliver, P. L., Schwab, M. H., Nave, K. A., Harrison, P. J., et al. (2009). Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport 20, 1523-1528. doi: 10.1097/WNR.0b013e328330f6e7.
20. Deakin, I. H., Nissen, W., Law, A. J., Lane, T., Kanso, R., Schwab, M. H., et al. (2012). Transgenic overexpression of the type I isoform of neuregulin 1 affects working memory and hippocampal oscillations but not long-term potentiation. Cereb. Cortex 22, 1520-1529. doi: 10.1093/cercor/bhr223.
21. Dean, B., Karl, T., Pavey, G., Boer, S., Duffy, L., and Scarr, E. (2008). Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice. Schizophr. Res. 99, 341-349. doi: 10.1016/j.schres.2007.10.013.
22. Del Pino, I., Garcia-Frigola, C., Dehorter, N., Brotons-Mas, J. R., Alvarez-Salvado, E., Martinez De Lagran, M., et al. (2013). Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron 79, 1152-1168. doi: 10.1016/j.neuron.2013.07.010.
23. Desbonnet, L., O'Tuathaigh, C., Clarke, G., O'Leary, C., Petit, E., Clarke, N., et al. (2012). Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: a putative model of gene x environment interaction. Brain Behav. Immun. 26, 660-671. doi: 10.1016/j.bbi.2012.02.010.
24. Duffy, L., Cappas, E., Lai, D., Boucher, A. A., and Karl, T. (2010). Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience 170, 800-807. doi: 10.1016/j.neuroscience.2010.07.042.
25. Duffy, L., Cappas, E., Scimone, A., Schofield, P. R., and Karl, T. (2008). Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1. Behav. Neurosci. 122, 748-759. doi: 10.1037/0735-7044.122.4.748.
26. Ehrlichman, R. S., Luminais, S. N., White, S. L., Rudnick, N. D., Ma, N., Dow, H. C., et al. (2009). Neuregulin 1 transgenic mice displayreduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res. 1294, 116-127. doi: 10.1016/j.brainres.2009.07.065.
27. Falls, D. L. (2003). Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 284, 14-30. doi: 10.1016/S0014-4827(02)00102-7.
28. Fazzari, P., Paternain, A. V., Valiente, M., Pla, R., Lujan, R., Lloyd, K., et al. (2010). Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 464, 1376-1380. doi: 10.1038/nature08928.
29. Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., et al. (2000). Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41-51. doi: 10.1016/S0896-6273(00) 00084-2.
30. Ferraro, T. N., Golden, G. T., Smith, G. G., St. Jean, P., Schork, N. J., Mulholland, N., et al. (1999). Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J. Neurosci. 19, 6733-6739.
31. Ferraro, T. N., Smith, G. G., Schwebel, C. L., Doyle, G. A., Ruiz, S. E., Oleynick, J. U., et al. (2010). Confirmation of multiple seizure susceptibility QTLs on chromosome 15 in C57BL/6J and DBA/2J inbred mice. Physiol. Genomics 42A, 1-7. doi: 10.1152/physiolgenomics.00096.2010.
32. Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R., et al. (1995). Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378, 390-394. doi: 10.1038/378390a0.
33. Golub, M. S., Germann, S. L., and Lloyd, K. C. (2004). Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav. Brain Res. 153, 159-170. doi: 10.1016/j.bbr.2003.11.010.
34. Gonzalez-Burgos, G., and Lewis, D. A. (2008). GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull. 34, 944-961. doi: 10.1093/schbul/sbn070.
35. Guidotti, A., Auta, J., Chen, Y., Davis, J. M., Dong, E., Gavin, D. P., et al. (2011). Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60, 1007-1016. doi: 10.1016/j.neuropharm.2010.10.021.
36. Guidotti, A., Auta, J., Davis, J. M., Dong, E., Grayson, D. R., Veldic, M., et al. (2005). GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology(Berl.) 180, 191-205. doi: 10.1007/s00213-005-2212-8.
37. Guidotti, A., Dong, E., Kundakovic, M., Satta, R., Grayson, D. R., and Costa, (2009). Characterization of the action of antipsychotic subtypes on valproate-inducedchromatinremodeling. TrendsPharmacol. Sci. 30, 55-60. doi: 10.1016/j.tips.2008.10.010.
38. Hahn, C. G., Wang, H. Y., Cho, D. S., Talbot, K., Gur, R. E., Berrettini, W. H., et al. (2006). Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. 12, 824-828. doi: 10.1038/nm1418.
39. Hall, J., Whalley, H. C., Job, D. E., Baig, B. J., McIntosh, A. M., Evans, K. L., et al. (2006). A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat. Neurosci. 9, 1477-1478. doi: 10.1038/nn1795.
40. Harrison, P. J., and Law, A. J. (2006). Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 60, 132-140. doi: 10.1016/j.biopsych.2005.11.002.
41. Harrison, P. J., and Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 40-68; image 45. doi: 10.1038/sj.mp.4001558
42. Hirokawa, T., Boon-Chieng, S., and Mitaku, S. (1998). SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 14, 378-379. doi: 10.1093/bioinformatics/14.4.378.
43. Honea, R., Verchinski, B. A., Pezawas, L., Kolachana, B. S., Callicott, J. H., Mattay, V. S., et al. (2009). Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage 45, 44-51. doi: 10.1016/j.neuroimage.2008.10.064.
44. Insel, T. R. (2010). Rethinking schizophrenia. Nature 468, 187-193. doi: 10.1038/nature09552.
45. Itoh, K., and Watanabe, M. (2009). Paradoxical facilitation of pentylenetetrazole- induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase. Neuroscience 159, 735-743. doi: 10.1016/j.neuroscience.2008.12.040.
46. Iwakura, Y., and Nawa, H. (2013). ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease. Front. Cell. Neurosci. 7:4. doi: 10.3389/fncel.2013.00004.
47. Johannessen, C. U. (2000). Mechanisms of action of valproate: a commentatory. Neurochem. Int. 37, 103-110. doi: 10.1016/S0197-0186(00)00013-9.
48. Kampman, O., Anttila, S., Illi, A., Saarela, M., Rontu, R., Mattila, K. M., et al. (2004). Neuregulin genotype and medication response in Finnish patients with schizophrenia. Neuroreport 15, 2517-2520. doi: 10.1097/00001756-20041115000017.
49. Karl, T., Burne, T. H., Van Den Buuse, M., and Chesworth, R. (2011). Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit? Behav. Brain Res. 223, 336-341. doi: 10.1016/j.bbr.2011.04.051.
50. Karl, T., Duffy, L., Scimone, A., Harvey, R. P., and Schofield, P. R. (2007). Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav. 6, 677-687. doi: 10.1111/j.1601-183X.2006.00298.x
51. Kato, T., Abe, Y., Sotoyama, H., Kakita, A., Kominami, R., Hirokawa, S., et al. (2011). Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. Mol. Psychiatry 16, 307-320. doi: 10.1038/mp. 2010.10.
52. Kato, T., Kasai, A., Mizuno, M., Fengyi, L., Shintani, N., Maeda, S., et al. (2010). Phenotypic characterization of transgenic mice overexpressing neuregulin-1. PLoS ONE 5:e14185. doi: 10.1371/journal.pone.0014185.
53. Kramer, R., Bucay, N., Kane, D. J., Martin, L. E., Tarpley, J. E., and Theill, L. E. (1996). Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc. Natl. Acad. Sci. U.S.A. 93, 4833-4838. doi: 10.1073/pnas.93.10.4833.
54. Krug, A., Markov, V., Krach, S., Jansen, A., Zerres, K., Eggermann, T., et al. (2010). The effect of Neuregulin 1 on neural correlates of episodic memory encoding and retrieval. Neuroimage 53, 985-991. doi: 10.1016/j.neuroimage.2009.12.062.
55. Kulkarni, J., Hayes, E., and Gavrilidis, E. (2012). Hormones and schizophrenia. Curr. Opin. Psychiatry 25, 89-95. doi: 10.1097/YCO.0b013e328350360e
56. Lacroix-Fralish, M. L., Tawfik, V. L., Nutile-McMenemy, N., Harris, B. T., and Deleo, J. A. (2006). Differential regulation of neuregulin 1 expression by progesterone in astrocytes and neurons. Neuron Glia Biol. 2, 227-234. doi: 10.1017/S1740925X07000385.
57. Lai, D., Liu, X. F., Forrai, A., Wolstein, O., Michalicek, J., Ahmed, I., et al. (2010). Neuregulin 1 sustains the gene regulatory network in both trabecular and nontrabecular myocardium. Circ. Res. 107, 715-U774. doi: 10.1161/Circresaha.110.218693.
58. Lai, W. S., Chang, C. Y., Wong, W. R., Pei, J. C., Chen, Y. S., and Hung, W. L. (2014). Assessing schizophrenia-relevant cognitive and social deficits in mice: a selection of mouse behavioral tasks and potential therapeutic compounds. Curr. Pharm. Des. doi: 10.2174/1381612819666140110122750. [Epub ahead ofprint].
59. Lai, W. S., Xu, B., Westphal, K. G., Paterlini, M., Olivier, B., Pavlidis, P., et al. (2006). Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc. Natl. Acad. Sci. U.S.A. 103, 16906-16911. doi: 10.1073/pnas.0604994103.
60. Law, A. J., Shannon Weickert, C., Hyde, T. M., Kleinman, J. E., and Harrison, P. J. Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 127, 125-136. doi: 10.1016/j.neuroscience.2004.04.026.
61. Lewis, C. M., Levinson, D. F., Wise, L. H., Delisi, L. E., Straub, R. E., Hovatta, I., et al. (2003). Genome scan meta-analysis ofschizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet. 73, 34-48. doi: 10.1086/376549.
62. Lewis, D. A., Hashimoto, T., and Volk, D. W. (2005). Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6, 312-324. doi: 10.1038/nrn1648.
63. Li, B., Woo, R. S., Mei, L., and Malinow, R. (2007). The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54, 583-597. doi: 10.1016/j.neuron.2007.03.028.
64. Liu, X., Hwang, H., Cao, L., Buckland, M., Cunningham, A., Chen, J., et al. (1998a). Domain-specific gene disruption reveals critical regulation of neuregulin signaling byits cytoplasmic tail. Proc. Natl. Acad. Sci. U.S.A. 95, 13024-13029. doi: 10.1073/pnas.95.22.13024.
65. Liu, X., Hwang, H., Cao, L., Wen, D., Liu, N., Graham, R. M., et al. (1998b). Release of the neuregulin functional polypeptide requires its cytoplasmic tail. J. Biol. Chem. 273, 34335-34340. doi: 10.1074/jbc.273.51.34335.
66. Loscher, W. (1999). Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog. Neurobiol. 58, 31-59. doi: 10.1016/S0301- 0082(98)00075-6.
67. Marenco, S., Geramita, M., Van Der Veen, J. W., Barnett, A. S., Kolachana, B., Shen, J., et al. (2011). Genetic association of ErbB4 and human cortical GABA levels in vivo. J. Neurosci. 31, 11628-11632. doi: 10.1523/JNEUROSCI.1529-11.2011.
68. Matrisciano, F., Tueting, P., Dalal, I., Kadriu, B., Grayson, D. R., Davis, J. M., et al. (2013). Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology 68, 184-194. doi: 10.1016/j.neuropharm.2012.04.013.
69. Mei, L., and Xiong, W. C. (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437-452. doi: 10.1038/nrn2392.
70. Meyer, D., and Birchmeier, C. (1995). Multiple essential functions of neuregulin in development. Nature 378, 386-390. doi: 10.1038/378386a0.
71. Michailov, G. V., Sereda, M. W., Brinkmann, B. G., Fischer, T. M., Haug, B., Birchmeier, C., et al. (2004). Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700-703. doi: 10.1126/science.1095862.
72. Neddens, J., and Buonanno, A. (2010). Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 20, 724-744. doi: 10.1002/hipo.20675.
73. ; promoter region SNP in NRG1 is associated with schizophreniarisk and type III isoform expression. Mol. Psychiatry 14, 741-743. doi: 10.1038/mp.2008.150.
74. Okada, M., and Corfas, G. (2004). Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse. Hippocampus 14, 337-344. doi: 10.1002/hipo.10185.
75. O'Tuathaigh, C. M., Babovic, D., O'Sullivan, G. J., Clifford, J. J., Tighe, O., Croke, D. T., et al. (2007). Phenotypic characterization of spatial cognition and social behavior in mice with "knockout" of the schizophrenia risk gene neuregulin 1. Neuroscience 147, 18-27. doi: 10.1016/j.neuroscience.2007.03.051.
76. O'Tuathaigh, C. M., Harte, M., O'Leary, C., O'Sullivan, G. J., Blau, C., Lai, D., et al. (2010). Schizophrenia-related endophenotypes in heterozygous neuregulin- 1 "knockout" mice. Eur. J. Neurosci. 31, 349-358. doi: 10.1111/j.1460- 9568.2009.07069.x
77. O'Tuathaigh, C. M., O'Connor, A. M., O'Sullivan, G. J., Lai, D., Harvey, R., Croke, D. T., et al. (2008). Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous "knockout" of the schizophrenia risk gene neuregulin-1. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 462-466. doi: 10.1016/j.pnpbp.2007.09.018.
78. O'Tuathaigh, C. M., O'Sullivan, G. J., Kinsella, A., Harvey, R. P., Tighe, O., Croke, D. T., et al. (2006). Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice. Neuroreport 17, 79-83. doi: 10.1097/01.wnr.0000192738.31029.0a
79. Parlapani, E., Schmitt, A., Wirths, O., Bauer, M., Sommer, C., Rueb, U., et al. (2010). Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients. World J. Biol. Psychiatry 11, 243-250. doi: 10.3109/15622970802022376.
80. Pedrique, S. P., and Fazzari, P. (2010). Nrg1 reverse signaling in cortical pyramidal neurons. J. Neurosci. 30, 15005-15006. doi: 10.1523/JNEUROSCI.4669- 10.2010.
81. Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., and Klein, P. S. (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734-36741. doi: 10.1074/jbc.M101287200.
82. Rimer, M., Barrett, D. W., Maldonado, M. A., Vock, V. M., and Gonzalez-Lima, E. (2005). Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport 16, 271-275. doi: 10.1097/00001756-200502280-00014.
83. Schwab, S. G., and Wildenauer, D. B. (2009). Update on key previously proposed candidate genes for schizophrenia. Curr. Opin. Psychiatry 22, 147-153. doi: 10.1097/YCO.0b013e328325a598.
84. Shamir, A., Kwon, O. B., Karavanova, I., Vullhorst, D., Leiva-Salcedo, E., Janssen, M. J., et al. (2012). The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J. Neurosci. 32, 2988-2997. doi: 10.1523/JNEUROSCI.1899-11.2012.
85. Shih, H. T., and Mok, H. K. (2000). ETHOM: event-recording computer software for the study of animal behavior. Acta Zool. Taiwan. 11, 47-61.
86. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892. doi: 10.1086/342734.
87. Steinthorsdottir, V., Stefansson, H., Ghosh, S., Birgisdottir, B., Bjornsdottir, S., Fasquel, A. C., et al. (2004). Multiple novel transcription initiation sites for NRG1. Gene 342, 97-105. doi: 10.1016/j.gene.2004.07.029.
88. Ting, A. K., Chen, Y., Wen, L., Yin, D. M., Shen, C., Tao, Y., et al. (2011). Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J. Neurosci. 31, 15-25. doi: 10.1523/jneurosci.2538-10.2011.
89. Tremolizzo, L., Carboni, G., Ruzicka, W. B., Mitchell, C. P., Sugaya, I., Tueting, P., et al. (2002). An epigenetic mouse model for molecular and behavioral neuropathologies relatedto schizophreniavulnerability. Proc. Natl. Acad. Sci. U.S.A. 99, 17095-17100. doi: 10.1073/pnas.262658999.
90. Tremolizzo, L., Doueiri, M. S., Dong, E., Grayson, D. R., Davis, J., Pinna, G., et al. (2005).Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol. Psychiatry 57, 500-509. doi: 10.1016/j.biopsych.2004.11.046.
91. Van Den Buuse, M., Wischhof, L., Lee, R. X., Martin, S., and Karl, T. (2009). Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. Int. J. Neuropsychopharmacol. 12, 1383-1393. doi: 10.1017/S1461145709000388.
92. Voineskos, D., De Luca, V., Macgregor, S., Likhodi, O., Miller, L., Voineskos, A. N., et al. (2009). Neuregulin 1 and age of onset in the major psychoses. J. Neural Transm. 116, 479-486. doi: 10.1007/s00702-008-0182-9.
93. Vullhorst, D., Neddens, J., Karavanova, I., Tricoire, L., Petralia, R. S., McBain, C. J., et al. (2009). Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J. Neurosci. 29, 12255-12264. doi: 10.1523/JNEUR0SCI.2454-09.2009.
94. Walker, R. M., Christoforou, A., Thomson, P. A., McGhee, K. A., Maclean, A., Muhleisen, T. W., et al. (2010). Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. Neurosci. Lett. 478, 9-13. doi: 10.1016/j.neulet.2010.04.056.
95. Walss-Bass, C., Liu, W., Lew, D. F., Villegas, R., Montero, P., Dassori, A., et al. (2006).A novel missense mutation in the transmembrane domain of neureg- ulin 1 is associated with schizophrenia. Biol. Psychiatry 60, 548-553. doi: 10.1016/j.biopsych.2006.03.017
96. Wen, L., Lu, Y. S., Zhu, X. H., Li, X. M., Woo, R. S., Chen, Y. J., et al. (2010). Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin- positive interneurons. Proc. Natl. Acad. Sci. U.S.A. 107, 1211-1216. doi: 10.1073/pnas.0910302107.
97. Wong, J., and Weickert, C. S. (2009). Transcriptional interaction of an estrogen receptor splice variant and ErbB4 suggests convergence in gene susceptibility pathways in schizophrenia. J. Biol. Chem. 284, 18824-18832. doi: 10.1074/jbc.M109.013243.
98. Wu, J., Zou, H., Strong, J. A., Yu, J., Zhou, X., Xie, Q., et al. (2005). Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice. Psychopharmacology 177, 256-263. doi: 10.1007/s00213-004-1944-1.
99. Yau, H. J., Wang, H. F., Lai, C., and Liu, F. C. (2003). Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb. Cortex 13, 252-264. doi: 10.1093/cercor/13.3.252